Evidence map›Paper›PMID 41628323›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Nuclear speckles are regulatory hubs for viral and host mRNA expression during HSV-1 infection.

Shani Nadav-Eliyahu, Chaya Bohrer, Alon Boocholez, Noa Kinor, Vesa Aho, Jennifer I C Benichou, Salla Mattola, Sami Salminen, Henri Niskanen, Minna U Kaikkonen and 2 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Nuclear speckles are regulatory hubs for viral and host mRNA expression during HSV-1 infection.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shani Nadav-EliyahuThe Mina and Everard Goodman Faculty of Life Sciences and Institute of Nanotechnology, Bar-Ilan University, Ramat Gan 5290002, Israel.ORCID 0009-0007-5810-8961
Chaya BohrerThe Mina and Everard Goodman Faculty of Life Sciences and Institute of Nanotechnology, Bar-Ilan University, Ramat Gan 5290002, Israel.
Alon BoocholezThe Mina and Everard Goodman Faculty of Life Sciences and Institute of Nanotechnology, Bar-Ilan University, Ramat Gan 5290002, Israel.ORCID 0000-0003-0471-226X
Noa KinorThe Mina and Everard Goodman Faculty of Life Sciences and Institute of Nanotechnology, Bar-Ilan University, Ramat Gan 5290002, Israel.
Vesa AhoDepartment of Biological and Environmental Science and Nanoscience Center, University of Jyvaskyla, Jyvaskyla 40500, Finland.
Jennifer I C BenichouThe Mina and Everard Goodman Faculty of Life Sciences and Institute of Nanotechnology, Bar-Ilan University, Ramat Gan 5290002, Israel.
Salla MattolaDepartment of Biological and Environmental Science and Nanoscience Center, University of Jyvaskyla, Jyvaskyla 40500, Finland.
Sami SalminenDepartment of Biological and Environmental Science and Nanoscience Center, University of Jyvaskyla, Jyvaskyla 40500, Finland.ORCID 0000-0001-6860-5135
Henri NiskanenA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio 70211, Finland.ORCID 0000-0002-8361-5531
Minna U KaikkonenA.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio 70211, Finland.
Maija Vihinen-RantaDepartment of Biological and Environmental Science and Nanoscience Center, University of Jyvaskyla, Jyvaskyla 40500, Finland.ORCID 0000-0003-0959-1153
Yaron Shav-TalThe Mina and Everard Goodman Faculty of Life Sciences and Institute of Nanotechnology, Bar-Ilan University, Ramat Gan 5290002, Israel.ORCID 0000-0002-8017-948X

Funding

European Union's Horizon 2020 101017116Foundation for the NIH (FNIH) U01DK127422-01Israel Science Foundation (ISF) 1278/18Jane and Aatos Erkko FoundationResearch Council of Finland (AKA) 330896
6 · The paper itself

Abstract

Herpes simplex virus type 1 (HSV-1) infection remodels the host nucleus, marginalizing chromatin and forming viral replication compartments (VRCs). Nuclear speckles, nuclear bodies enriched in RNA-processing factors, reposition around VRCs and undergo structural changes. While viral mRNAs are transcribed in VRCs and host transcription is largely suppressed, the nuclear routes used by viral and upregulated host transcripts and their relationship with nuclear bodies remain unclear. We show that immediate-early (IE) viral transcripts uniquely accumulate in nuclear speckles prior to export, unlike early or late transcripts, revealing a selective nuclear speckle-dependent pathway. Similarly, host mRNAs upregulated during infection traffic into nuclear speckles after transcription. Moreover, nuclear speckles are structurally remodeled, marked by the long non-coding RNA (lncRNA) MALAT1 removal and increased dynamics of the nuclear speckle core protein SRRM2. Finally, we found that blocking mRNA export causes IE transcripts to accumulate in nuclear speckles and that nuclear speckle disassembly severely impairs IE mRNA export, preventing downstream viral gene expression. These findings establish nuclear speckles as dynamic regulatory hubs that selectively facilitate the processing and export of IE viral mRNAs during HSV-1 infection.

Indexed as

Herpes SimplexHerpesvirus 1, HumanNuclear SpecklesRNA, MessengerRNA, ViralAnimalsCell NucleusGene Expression Regulation, ViralHost-Pathogen InteractionsHumansRNA, Long NoncodingVirus ReplicationRNA, Long NoncodingRNA, MessengerRNA, ViralHSV-1nuclear organizationnuclear specklesRNA expressionRNA FISH

Identifiers

PMID41628323
PMCPMC12891004

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.